Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases
Acquiring Company
Eli Lilly and Company
Acquired Company
Akouos, Inc.
IndianapolisBostonManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareGeneticsTherapeuticsDescription
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The acquisition expands Lilly's efforts in genetic medicines to include Akouos's portfolio of potential first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss.
Quick answer
Eli Lilly and Company is acquiring Akouos, Inc., announced December 1, 2022. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- Who acquired Akouos, Inc?
- Eli Lilly and Company agreed to acquire Akouos, Inc. on December 1, 2022.
- How much did Eli Lilly and Company pay for Akouos, Inc?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and Akouos, Inc. based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. Akouos, Inc. is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly To Acquire Akouos To Discover And Develop Treatments For Hearing Loss (October 18, 2022)
- Prenetics Acquires Act Genomics, Creating A Leader In Comprehensive Cancer Genetics And Precision Oncology (December 16, 2022)
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
- Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio (December 1, 2022)
- Rocket Pharmaceuticals Completes Acquisition Of Renovacor (December 1, 2022)
- Sonic Healthcare Acquires Strategic Stake In Microba Life Sciences, Establishes Significant Commercial Partnership (November 29, 2022)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Akouos, Inc.?
Akouos, Inc. was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on December 1, 2022. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Akouos, Inc.?
Eli Lilly and Company's acquisition of Akouos, Inc. was reported on December 1, 2022. Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Akouos, Inc. do?
Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.